Vice President JD Vance and CMS Administrator Mehmet Oz announced on September 22, 2026 that the White House Task Force to Eliminate Fraud had removed 760,000 people from ACA exchange plans at the end of August and placed another 419,000 under additional verification — together roughly 6% of the 19.2 million currently enrolled. The administration framed the action as a fraud crackdown, citing 40 agents and brokers allegedly tied to 50,000 fraudulent enrollments and $45M in improper subsidies; CMS separately terminated more than 200 brokers and barred new broker enrollments for plan year 2027. Vance pegged the savings at $2.2 billion in recovered premium tax credits, a figure Bloomberg Tax said could not be immediately reconciled to public CMS data.
Enrollees removed (end of Aug)
760,000
CMS, announced Sept. 22, 2026
Under additional verification
419,000
White House Task Force to Eliminate Fraud
Claimed taxpayer savings
$2.2B
Per VP Vance; not independently verified by CMS
Current ACA enrollment base
19.2M
ASPE report, Jun 26, 2026
Brokers terminated (YTD)
200+
CMS, plus 569 notices of intent to terminate
Same-Day Trading: Stocks Priced the Sicker-Pool Risk
The Bloomberg Tax tape captured the intraday repricing within minutes of the Vance announcement. Insurer shares fell in lockstep with their ACA exchange exposure. Oscar Health — almost a pure-play exchange carrier with 1.2M Florida members and another 359K in Texas — dropped as much as 6.6%. Centene, whose Commercial segment is overwhelmingly ACA marketplace, slipped 3.9%. Molina Healthcare, which had already cut 2026 EPS guidance by $1.50 per share because the sickest members refused to leave, slid 3.5%. Elevance Health, where the Individual/ACA book is a much smaller slice of $201B in total revenue, gave back 1.9%. The clean ranking — by pure-play exchange exposure — tells investors the market is treating this as a volume and risk-adjustment event, not a margin windfall.
| Company | Ticker | Intraday move | ACA exchange exposure |
|---|---|---|---|
| Oscar Health | OSCR | −6.6% | ~100% of premium revenue |
| Centene | CNC | −3.9% | Commercial (mostly ACA) was 87.9% MLR in 2025 |
| Molina Healthcare | MOH | −3.5% | Marketplace membership fell to 283K (from 655K YE 2025) |
| Elevance Health | ELV | −1.9% | $9.3B Individual/ACA revenue in 2025 vs. $197.6B total |
The Insurer Exposure Map: From Pure-Play to Footnote
- Centene is the largest ACA exchange carrier, with 3.5M marketplace members at Q2 2026 (down from 5.9M a year earlier). The company raised full-year 2026 adjusted EPS guidance to more than $4.80 — up from >$3.40 — and lifted its marketplace pretax-margin outlook to 4.5%–5% from 3%, explicitly because the people exiting are healthier than the ones staying.
- Molina Healthcare is the cleanest pure-play on the bearish side: marketplace membership collapsed to 283,000 in Q2 2026 from 655,000 at year-end 2025, and management has guided to another $1B marketplace revenue cut for 2027. Its marketplace MCR jumped to 88.9% in Q2 2026 from 85.4% a year ago.
- Oscar Health is the most levered to the fraud crackdown: the company disclosed in August that 250,000–300,000 of its members could be retroactively disenrolled. Yet the underlying book is profitable — Q1 2026 net income hit $679M on $4.6B revenue — so any retrenchment costs will be partially offset by a less-sick remaining pool.
- Elevance Health carries Individual/ACA revenue of $9.3B in 2025 (per its 10-K, up from $8.3B in 2024) inside a $197.6B revenue base. ACA is a footnote for ELV, but the company also lowered 2026 revenue expectations in late January.
- UnitedHealth Group runs an exchange book that executives have described as performing ahead of expectations in 2026; the carrier pledged to return any excess exchange profits to enrollees — a quiet acknowledgment that the sicker-pool math is real.
Crucially, the headline760K is only one slice of the broader integrity push. HHS ASPE estimated in June 2026 that about 5.6 million of 2025 ACA enrollments were improper, phantom, or fraudulent — meaning a similar disclosure could land again before year-end. The market is pricing insurers as if more cuts are coming.
Hospitals: The Other Side of the Coin
For hospitals, the same policy that lifts insurer margins compresses their payer mix. Disenrolled exchange enrollees do not vanish from the emergency room — they show up as self-pay. And self-pay, by industry convention, generates little to no recognized revenue.
- HCA Healthcare raised its full-year payer-mix hit estimate to $1B–$1.2B (from $600M–$900M in April), with roughly $400M of that concentrated in Q2 2026 alone. CEO Sam Hazen told analysts exchange patients \"migrated almost one for one to uninsured,\" a worse outcome than the 80–85% uninsured-substitution rate HCA originally assumed.
- Tenet Healthcare reported Q2 2026 exchange revenue down 17% year-over-year, exchange admissions down 13.5%, and a $65M revenue headwind concentrated in Florida, Arizona, Michigan, South Carolina, and Texas. The company still raised full-year adjusted EBITDA guidance to $4.83B–$5.03B thanks to ambulatory-mix gains, but the exchange line is now visibly shrinking.
- Universal Health Services saw exchange volumes fall 15% in Q2 2026, replaced by self-pay; management warned the $50M H2 2026 headwind will continue at a similar pace into 2027 unless coverage trends reverse.
- Community Health Systems doubled its full-year EBITDA hit estimate to $50M–$75M (from $20M–$30M). Self-pay rose to just over 6% of visits from slightly under 5% a year earlier. CEO Kevin Hammons summed it up bluntly: the company collects \"only a few pennies on the dollar\" from self-pay and is \"effectively not recognizing any revenue on that self-pay business.\"
The Sicker-Pool Paradox: Why Insurers Rallied Their Guides
The single most important causal chain in this story is non-obvious: removing enrollees does not simply shrink insurer revenue proportionally. It tilts the remaining pool toward sicker members, which is bearish on volume but bullish on pricing power — because the next round of 2027 ACA rate filings will be built on a higher morbidity baseline.
The data already confirms this. Wakely reported a 12.0% drop in ACA enrollment from January–April 2025 to the same window in 2026, paired with a 6.3% increase in normalized relative risk. Claimant ratios ticked up 0.2%, and the share of enrollees with at least one hierarchical condition category rose 0.6%. In other words: fewer people, sicker mix. That is precisely why Centene was able to raise its marketplace pretax-margin guide from 3% to 4.5%–5% even as membership fell, and why Molina Healthcare is preparing to shrink its marketplace footprint again for 2027 rather than chase top-line in a market where the math no longer rewards volume.
Catalysts to Watch: 419K, the Broker Lockout, and 2027 Rate Filings
- The 419,000 enrollees flagged for verification are the next shoe to drop. If CMS follows the same retroactive pattern, that cohort could trigger a Q4 2026 or Q1 2027 restatement wave — especially for Oscar Health, which has the most concentrated geographic exposure (Florida 1.18M, Texas 359K, Georgia 219K of its 2M+ membership).
- CMS is barring new brokers and agents from enrolling people for plan year 2027. That removes a key distribution channel just as open enrollment begins — historically a5–10% drag on new-member acquisition for carriers.
- 2027 ACA rate filings will be built on the post-purge morbidity baseline. Insurers that already repriced aggressively (Molina set average 2026 rate increases of roughly 30%) will likely push for further double-digit increases; the question is whether state regulators allow it.
- Midterm positioning: the policy arrived in the same news cycle that Republicans are framing as an anti-fraud victory. Hospitals and not-for-profit systems (CommonSpirit Health, among others) face escalating uncompensated-care costs — a Democratic midterm ad waiting to happen if exchange losses compound through 2027.
The 2026 midterm-sector reprice thesis already in the market — which previously centered on the $500 per-user ACA exchange user-fee cut — just expanded by an order of magnitude. Today's action is a structural shift in the exchange population, not a one-time fee adjustment.
Stocks in the Trade
- Most levered to retroactive CMS fraud-driven disenrollments: 250K–300K of its 2M members could be pulled, compressing 2027 revenue by an outsized share.
- Q1 2026 net income of $679M and 50%+ membership growth show the book is profitable — but the sicker-pool math means any future rate filings will be built on a worse morbidity baseline.
- Concentration risk: ~59% of membership sits in Florida alone, leaving Oscar Health exposed to the same broker lockout and verification wave that hit hardest there.
- Raised 2026 adjusted EPS guide to >$4.80 from >$3.40 because sicker members stay while healthier members leave — a structural margin tailwind.
- Marketplace membership fell to 3.5M in Q2 2026 (from 5.9M a year ago), capping top-line; Q2 commercial MLR improved to 79.2% from 90.6%, validating the rate-increase thesis.
- If the additional 419K verification cohort triggers another retroactive wave, Centene is the carrier with the most absolute members at risk, but also the most diversified beyond ACA.
- Marketplace membership collapsed to 283K in Q2 2026 from 655K at YE 2025 — already the steepest cut in the cohort, with another $1B revenue reduction planned for 2027.
- Marketplace MCR jumped to 88.9% in Q2 2026 from 85.4% a year ago, eroding the pricing cushion Molina used to underwrite its 2026 book.
- Management is shrinking footprint rather than chasing volume — a clear signal that further CMS integrity actions will not be revenue-neutral.
- Smallest exposure: $9.3B Individual/ACA revenue in 2025 (per 10-K) inside a $197.6B total — the stock's 1.9% intraday drop is disproportionate to economic impact, so it screens as an overreaction.
- Lowered 2026 revenue expectations already in January; any further cut would be incremental rather than structural.
- Watch the Elevance Health Q3 2026 print for Individual segment margin commentary — a guide-raise would confirm the margin tailwind thesis is sector-wide.
- Full-year payer-mix hit raised to $1B–$1.2B (from $600M–$900M), with $400M concentrated in Q2 2026 alone — the largest single-name hospital exposure to ACA enrollment loss.
- CEO Hazen said exchange patients 'migrated almost one for one to uninsured' — worse than the 80–85% substitution rate originally assumed, signaling more pressure ahead.
- The 760K removal plus 419K verification suggests Q3/Q4 self-pay mix will keep rising; HCA's $425 stock has14% of float held by insiders, so watch for any Form 4 buying as a contrarian tell.
- Q2 2026 exchange revenue down 17% year-over-year, admissions down 13.5%, $65M revenue headwind concentrated in FL, AZ, MI, SC, TX — directly aligned with the Vance-removal geography.
- Despite the headwind, raised full-year adjusted EBITDA to $4.83B–$5.03B — confirming ASC mix can offset ACA losses for now, but masking the structural shift.
- Watch for Tenet Healthcare 2027 ACA rate filings in its hospital segment; if exchange patients continue migrating to self-pay, the5.5% exchange share of revenue will keep shrinking.
- Full-year EBITDA hit estimate doubled to $50M–$75M, with self-pay rising to >6% of visits from <5% — a measurable payer-mix deterioration concentrated in rural markets.
- CEO Hammons: 'effectively not recognizing any revenue' on self-pay — the cleanest articulation in the cohort of why ACA losses translate into hospital earnings losses.
- Already trading at distressed multiples (TTM revenue ~$12B, market cap reflects skepticism); any further ACA removal wave would compound the 2026 EBITDA cut.
